Ciprofibrate therapy in patients with hypertriglyceridemia and low high-density lipoprotein [HDL]-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight [the ciproamlat study]

ABSTRACT

Background: hypertriglyceridemia, in combination with low HDL cholesterol levels, is a risk factor for cardiovascular disease. Our objective was to evaluate the efficacy of Ciprofibrate for the treatment of this form of dyslipidemia and to identify factors associated with better treatment response